HIV and Global Cardiovascular Health. [Review] (Record no. 400)

MARC details
000 -LEADER
fixed length control field 02133nam a22003497a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220926s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1523-3782
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s11886-022-01741-1 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s11886-022-01741-1 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 35802233
245 ## - TITLE STATEMENT
Title HIV and Global Cardiovascular Health. [Review]
251 ## - Source
Source Current Cardiology Reports. 2022 Jul 08
252 ## - Abbreviated Source
Abbreviated source Curr Cardiol Rep. 2022 Jul 08
253 ## - Journal Name
Journal name Current cardiology reports
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2022 Jul 08
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2022-09-26
520 ## - SUMMARY, ETC.
Abstract PURPOSE OF REVIEW: Because of effective combination antiretroviral therapy, people living with HIV (PLWH) are living longer but developing chronic age-related conditions including cardiovascular disease (CVD), the leading cause of death globally. This review aims to discuss the epidemiology, mechanisms, and clinical considerations of CVD in PLWH from a global perspective.
520 ## - SUMMARY, ETC.
Abstract RECENT FINDINGS: PLWH are at greater risk for CVD at chronologically younger ages than those without HIV. Potential underlying mechanisms for CVD in PLWH include systemic inflammation, comorbidities, immune-mediated, or treatment-related mechanisms. There is also risk factor variation based on geographical location, including non-traditional CVD risk factors. CVD is prevalent in PLWH and increasing on a global scale. Further understanding the unique epidemiology, risk factors, and treatment of CVD in this population will improve the care of PLWH. Copyright © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute, Baltimore
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Review
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Woldu, Bethel
790 ## - Authors
All authors Goerlich E, Hays AG, Post WS, Wagle A, Woldu B, Wu KC
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1007/s11886-022-01741-1">https://dx.doi.org/10.1007/s11886-022-01741-1</a>
Public note https://dx.doi.org/10.1007/s11886-022-01741-1
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 09/26/2022   35802233 35802233 09/26/2022 09/26/2022 Journal Article

Powered by Koha